Skip to content

Boston Scientific BSX Interest coverage

Interest coverage at other companies

Abbott logo
AbbottABT
14.4×+1.4×
Johnson & Johnson logo
Johnson & JohnsonJNJ
24.5×-1.7×
Stryker logo
StrykerSYK
-3.0×
Edwards Lifesciences logo
Edwards LifesciencesEW
62×-7.7×
Medtronic logo
MedtronicMDT
9.1×+0.9×
STERIS logo
STERISSTE
18.1×+8.1×

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Calculated from Boston Scientific’s reported figures.

Based on trailing twelve months.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's interest coverage?
Boston Scientific (BSX) reported interest coverage of 10.6× in Q1 2026.
How has Boston Scientific's interest coverage changed year-over-year?
Boston Scientific's interest coverage increased by 18.6% year-over-year, from 9× to 10.6×.
What is the long-term trend for Boston Scientific's interest coverage?
Over 3 years (2022 to 2025), Boston Scientific's interest coverage has grown at a 49.7% compound annual growth rate (CAGR), from 11.6× to 39×.
What does interest coverage mean?
How many times the company's operating profit covers its interest bill.
How do you interpret interest coverage?
Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
How does interest coverage compare across companies?
Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.